Department of Nephrology, The Third Affiliated Hospital of Soochow University, Changzhou, P.R. China.
Division of Nephrology, West China Hospital, Kidney Research Institute, Sichuan University, Chengdu, P.R. China.
Ren Fail. 2020 Nov;42(1):629-637. doi: 10.1080/0886022X.2020.1786400.
Immunoglobulin A nephropathy (IgAN) is a clinical and pathological syndrome with heterogenous manifestation and progression. Complement activation is involved in the disease. However, the clinical significance of C4 deposition in IgAN is obscure.
A multicenter retrospective study was conducted in biopsy-proven IgAN patients. Based on mesangial C4 deposition, patients were divided into two groups. The baseline clinical data and immunopathological phenotypes were compared. The composite endpoint was defined as eGFR decline greater than 50%, doubling of baseline serum creatinine, the occurrence of end-stage renal disease (ESRD).
A total of 642 IgAN patients were recruited, with 41 patients showing mesangial C4 deposition. The mesangial C4 positive group showed lower serum albumin, higher proteinuria, and a higher rate of IgG, IgM, and C1q mesangial deposition. After a median follow-up of 43.18 months, 81 (12.62%) patients achieved the composite endpoint. The multivariate Cox regression models identified glomerular C4 deposition (hazard ratios [HR] = 3.22, 95% confidence intervals [CI] = 1.51-6.87, < 0.01), global sclerosis (G1 vs. G0, HR = 1.90, 95%CI = 1.02-3.52, = 0.04; G2 vs. G0, HR = 3.72, 95%CI = 1.98-7.00, < 0.01), male (HR = 1.80, 95%CI = 1.10-2.97, = 0.02), serum creatinine (HR = 1.01, 95%CI = 1.00-1.01, < 0.01), triglyceride (HR = 1.17, 95%CI = 1.01-1.35, = 0.04), proteinuria (HR = 1.07, 95%CI = 1.01-1.13, = 0.02), serum C3 level (HR = 0.05, 95%CI = 0.01-0.25, < 0.01), and serum C4 level (HR = 99.59, 95%CI = 8.69-1140.89, < 0.01) as independent risk factors for poor renal outcomes.
Glomerular mesangial C4 deposition and global sclerosis are independent predictors for poor prognosis in IgAN patients.
免疫球蛋白 A 肾病(IgAN)是一种临床表现和进展具有异质性的临床和病理综合征。补体激活参与了该疾病的发生。然而,IgAN 中 C4 沉积的临床意义尚不清楚。
对经活检证实的 IgAN 患者进行了一项多中心回顾性研究。根据系膜 C4 沉积情况,将患者分为两组。比较两组的基线临床数据和免疫病理表型。复合终点定义为 eGFR 下降大于 50%、基线血清肌酐倍增、终末期肾病(ESRD)的发生。
共纳入 642 例 IgAN 患者,其中 41 例表现为系膜 C4 沉积。系膜 C4 阳性组的血清白蛋白较低,蛋白尿较高,且 IgG、IgM 和 C1q 系膜沉积的发生率较高。中位随访 43.18 个月后,81 例(12.62%)患者达到复合终点。多变量 Cox 回归模型确定了肾小球 C4 沉积(风险比 [HR] = 3.22,95%置信区间 [CI] = 1.51-6.87, < 0.01)、全球硬化(G1 与 G0,HR = 1.90,95%CI = 1.02-3.52, = 0.04;G2 与 G0,HR = 3.72,95%CI = 1.98-7.00, < 0.01)、男性(HR = 1.80,95%CI = 1.10-2.97, = 0.02)、血清肌酐(HR = 1.01,95%CI = 1.00-1.01, < 0.01)、甘油三酯(HR = 1.17,95%CI = 1.01-1.35, = 0.04)、蛋白尿(HR = 1.07,95%CI = 1.01-1.13, = 0.02)、血清 C3 水平(HR = 0.05,95%CI = 0.01-0.25, < 0.01)和血清 C4 水平(HR = 99.59,95%CI = 8.69-1140.89, < 0.01)是不良肾脏结局的独立危险因素。
肾小球系膜 C4 沉积和全球硬化是 IgAN 患者预后不良的独立预测因素。